In a first-of-its-kind breakthrough study targeting corneal Schwann cells for drug discovery, the Mohan Lab has identified Dickkopf-related protein 1 (DKK1) as a novel, druggable target for promoting axonal regeneration and restoring corneal sensitivity. Using a broad experimental strategy, the team defined DKK1’s role in corneal injury across two clinically relevant models: surgical lesions in […]